Not applicableStudy completedNCT01488357What this trial is testingPatient Preferences for Breast Reconstruction After MastectomyWho this might be right forBreast Cancer UNC Lineberger Comprehensive Cancer Center 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69
Large-scale testing (Phase 3)Enrolling By InvitationNCT05645536What this trial is testingSafety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyWho this might be right forBreast Cancer Tolmar Inc. 250
Testing effectiveness (Phase 2)Study completedNCT02687490What this trial is testingAbraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Fudan University 81
Not applicableStudy completedNCT01598597What this trial is testingAn Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)Who this might be right forBreast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Early research (Phase 1)Study completedNCT00372424What this trial is testingStudy Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 PositiveWho this might be right forBreast Cancer Pfizer 26
Not applicableActive Not RecruitingNCT05926024What this trial is testingLong-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary TreatmentWho this might be right forBreast Cancer UNC Lineberger Comprehensive Cancer Center 253
Large-scale testing (Phase 3)Study completedNCT00201942What this trial is testingPET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)Who this might be right forBreast Cancer Ontario Clinical Oncology Group (OCOG) 336
Early research (Phase 1)Ended earlyNCT01891669What this trial is testingPF-06263507 In Patients With Advanced Solid TumorsWho this might be right forNeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more Pfizer 26
Not applicableNot Yet RecruitingNCT07497191What this trial is testingAMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast CancerWho this might be right forBreast CancerPerimenopauseOvarian Reserve Shengjing Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02102490What this trial is testingAbemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has SpreadWho this might be right forMetastatic Breast Cancer Eli Lilly and Company 132
Not applicableStudy completedNCT07072013What this trial is testingAn Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 1,937
Not applicableStudy completedNCT01220960What this trial is testingArt Therapy Intervention for Breast Cancer PatientsWho this might be right forBreast Cancer Dr. Sarkis Meterissian 64
Testing effectiveness (Phase 2)Study completedNCT01356862What this trial is testingPasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast CancerWho this might be right forBreast Cancer Alliance Pour La Recherche en Cancerologie 91
Testing effectiveness (Phase 2)Study completedNCT00463788What this trial is testingCetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast CancerWho this might be right forBreast Neoplasm Merck KGaA, Darmstadt, Germany 181
Early research (Phase 1)Study completedNCT00001270What this trial is testingFeasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and LymphomaWho this might be right forBreast NeoplasmsLymphomaNeoplasm Metastasis+1 more National Cancer Institute (NCI) 85
Not applicableUnknownNCT04489992What this trial is testingExperiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare SystemWho this might be right forAI (Artificial Intelligence)Mammary CancerLung Cancer+6 more Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 133,000
Not applicableEnded earlyNCT02581709What this trial is testingAn Intervention Programme to Reduce Cognitive Impairment Due to CancerWho this might be right forBreast NeoplasmsColorectal Neoplasms Queen's University, Belfast 15
Not applicableNot Yet RecruitingNCT07649902What this trial is testingArtificial Intelligence Powered Digital Education Based on the Neuman Systems Model for Breast Cancer Patients Receiving RadiotherapWho this might be right forBreast CancerRadiodermatitis Ataturk University 38